Nonopioid medication for the relief of refractory breathlessness

被引：3
作者：
Awan, Sarah [1 ]
Wilcock, Andrew [2 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Dept Palliat Care, Nottingham, England
[2] Univ Nottingham, Sch Med, Div Canc & Stem Cells, Nottingham, England
来源：
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE | 2015年 / 9卷 / 03期
关键词：
antidepressants; anxiolytics; cannabinoids; furosemide; phenothiazines; SUSTAINED-RELEASE MORPHINE; NEBULIZED FUROSEMIDE; EXERCISE TOLERANCE; DYSPNEA; MANAGEMENT; PROMETHAZINE; DEPRESSION; BUSPIRONE; CANCER; PILOT;
D O I：
10.1097/SPC.0000000000000149
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Purpose of review To provide an overview of recent evidence relating to nonopioid medication for the treatment of refractory breathlessness. Recent findings A search of publications since 2013 found systematic reviews on phenothiazines and nebulized medications, together with one study examining the use of benzodiazepines and another nebulized furosemide. However, all provided limited data and concluded that further clinical trials are required. Summary Based on this review, there is insufficient evidence to support the routine use of nonopioid medication in the treatment of refractory breathlessness.
引用
收藏
页码：227 / 231
页数：5
相关论文
共 30 条
  • [1] Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea
    Abernethy, AP
    Currow, DC
    Frith, P
    Fazekas, BS
    McHugh, A
    Bui, C
    [J]. BRITISH MEDICAL JOURNAL, 2003, 327 (7414): : 523 - 526
  • [2] Ahmedzai S, 1988, RESP DIS PRACT, V5, P21
  • [3] Untangling Therapeutic Ingredients of a Personalized Intervention for Patients with Depression and Severe COPD
    Alexopoulos, George S.
    Kiosses, Dimitris N.
    Sirey, Jo Anne
    Kanellopoulos, Dora
    Seirup, Joanna K.
    Novitch, Richard S.
    Ghosh, Samiran
    Banerjee, Samprit
    Raue, Patrick J.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 22 (11) : 1316 - 1324
  • [4] The Role of Benzodiazepines in Breathlessness: A Single Site, Open Label Pilot of Sustained Release Morphine Together with Clonazepam
    Allcroft, Peter
    Margitanovic, Vera
    Greene, Aine
    Agar, Meera R.
    Clark, Katherine
    Abernethy, Amy P.
    Currow, David C.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2013, 16 (07) : 741 - 744
  • [5] ARGYROPOULOU P, 1993, RESPIRATION, V60, P216
  • [6] IMPROVEMENT IN MOOD, PHYSICAL SYMPTOMS, AND FUNCTION WITH NORTRIPTYLINE FOR DEPRESSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    BORSON, S
    MCDONALD, GJ
    GAYLE, T
    DEFFEBACH, MPHM
    LAKSHMINARAYAN, S
    VANTUINEN, C
    [J]. PSYCHOSOMATICS, 1992, 33 (02) : 190 - 201
  • [7] Nebulized Medications for the Treatment of Dyspnea: A Literature Review
    Boyden, Jackelyn Y.
    Connor, Stephen R.
    Otolorin, Lily
    Nathan, Steven D.
    Fine, Perry G.
    Davis, Malene S.
    Muir, J. Cameron
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (01) : 1 - 19
  • [8] The frequency and correlates of dyspnea in patients with advanced cancer
    Bruera, E
    Schmitz, B
    Pither, J
    Neumann, CM
    Hanson, J
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (05) : 357 - 362
  • [9] Bushunow PW, 2011, J CLIN ONCOL S, V29
  • [10] Breathlessness in an age of noncommunicable diseases
    Currow, David C.
    Abernethy, Amy P.
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2012, 6 (02) : 127 - 128
123